BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 1, 2007
View Archived Issues
The novel Spigelmer mNOX-E36 shows promise in mouse models of lupus
Read More
Snapshots: Recent clinical results in COPD
Read More
Similar efficacy seen with ibandronate and alendronate in postmenopausal osteoporosis
Read More
Agenix recruits first patient for phase II study of ThromboView for PE detection
Read More
ThromboGenics completes patient enrollment in MIVI IIT trial
Read More
Update on Curis' CUDC-101 and targeted cancer drug development platform
Read More
Labopharm requests meeting with FDA regarding NDA for once-daily tramadol
Read More
MerLion begins phase I trials of finafloxacin for H. pylori
Read More
Positive results for Orexigen's two phase I trials of naltrexone SR
Read More
Patient dosing begins in DiObex's phase IIb trial of type 2 diabetes drug
Read More
Keryx sells Zerenex licensing to JT and Torii for development and marketing in Japan
Read More
Positive preliminary results from Arena's phase II trial of APD-125 for insomnia
Read More
Tocosol Paclitaxel does not meet primary endpoint in study in metastatic breast cancer
Read More
ISTA licenses North American rights to nasal bepotastine from Tanabe Seiyaku
Read More
PMDA recommends additional trial for Chugai's new Epogin injection indication
Read More
Taisho and BCI sign license agreement for novel compounds for CNS indications
Read More
U.S. awards USD 15 million to GeoVax's HIV/AIDS vaccine program
Read More
EMEA recommends amendment to prescribing information for ESAs in the E.U.
Read More
Positive results for Pharmacopeia's phase I confirmation study of PS-433540
Read More
Novel class of HIV-1 integrase inhibitors with distinct mechanism of strand transfer inhibition
Read More
Antivirulence DltA inhibitors enhance host's innate immunity against Gram-positive infections
Read More
Novel tachykinin NK1 receptor antagonists emerge from Tanabe Seiyaku R&D
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
AstraZeneca prepares and tests novel beta2-adrenoceptor agonists
Read More
Novartis' Galvus approved in combination with oral antidiabetes medicines in Europe
Read More
Vanda submits NDA to FDA for iloperidone for schizophrenia
Read More
CV Therapeutics submits sNDA to FDA to expand Ranexa label
Read More
FDA approves Daiichi's once-daily Azor for hypertension
Read More
Update on Pfizer's study of CCR5 antagonist Selzentry for HIV
Read More